Sulfonylurea receptor 1 in central nervous system injury: a focused review.

Simard, J Marc; Woo, S Kyoon; Schwartzbauer, Gary T; Gerzanich, Volodymyr

The sulfonylurea receptor 1 (Sur1)-regulated NCCa-ATP channel is a nonselective cation channel that is regulated by intracellular calcium and adenosine triphosphate. The channel is not constitutively expressed, but is transcriptionally upregulated de novo in all cells of the neurovascular unit, in many forms of central nervous system (CNS) injury, including cerebral ischemia, traumatic brain injury (TBI), spinal cord injury (SCI), and subarachnoid hemorrhage (SAH). The channel is linked to microvascular dysfunction that manifests as edema formation and delayed secondary hemorrhage. Also implicated in oncotic cell swelling and oncotic (necrotic) cell death, the channel is a major molecular mechanism of 'accidental necrotic cell death' in the CNS. In animal models of SCI, pharmacological inhibition of Sur1 by glibenclamide, as well as gene suppression of Abcc8, prevents delayed capillary fragmentation and tissue necrosis. In models of stroke and TBI, glibenclamide ameliorates edema, secondary hemorrhage, and tissue damage. In a model of SAH, glibenclamide attenuates the inflammatory response due to extravasated blood. Clinical trials of an intravenous formulation of glibenclamide in TBI and stroke underscore the importance of recent advances in understanding the role of the Sur1-regulated NCCa-ATP channel in acute ischemic, traumatic, and inflammatory injury to the CNS.

SULFONYLUREAS; CENTRAL nervous system injuries; ION channels; INTRACELLULAR calcium; PHYSIOLOGICAL effects of adenosine triphosphate; CEREBRAL ischemia; GLIBENCLAMIDE

Journal of Cerebral Blood Flow & Metabolism, 2012, Vol 32, Issue 9, p1699

0271-678X

Academic Journal

10.1038/jcbfm.2012.91